Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-21

FDA Approved: CARBIDOPA — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for carbidopa tablets from Oceanside Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa (Carbidopa)

Snippet

SUPPL AP for CARBIDOPA (CARBIDOPA TABLETS)